229 related articles for article (PubMed ID: 31118348)
21. Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity.
Agha A; Carpenter R; Bhattacharya S; Edmonson SJ; Carlsen E; Monson JP
J Endocrinol Invest; 2007 Feb; 30(2):145-9. PubMed ID: 17392605
[TBL] [Abstract][Full Text] [Related]
22. Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants.
de Krijger RR; Papathomas TG
Virchows Arch; 2012 Jan; 460(1):9-18. PubMed ID: 22086150
[TBL] [Abstract][Full Text] [Related]
23. [Myxoid variant of adrenocortical carcinoma].
Jeremie G; Lifante JC; Chazot FB; Sajous C; Raymond P; Decaussin-Petrucci M
Ann Pathol; 2021 Apr; 41(2):186-191. PubMed ID: 33549334
[TBL] [Abstract][Full Text] [Related]
24. Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior.
Papotti M; Volante M; Duregon E; Delsedime L; Terzolo M; Berruti A; Rosai J
Am J Surg Pathol; 2010 Jul; 34(7):973-83. PubMed ID: 20534995
[TBL] [Abstract][Full Text] [Related]
25. A case of ACTH-independent macronodular adrenal hyperplasia associated with multiple endocrine neoplasia type 1.
Yoshida M; Hiroi M; Imai T; Kikumori T; Himeno T; Nakamura Y; Sasano H; Yamada M; Murakami Y; Nakamura S; Oiso Y
Endocr J; 2011; 58(4):269-77. PubMed ID: 21415556
[TBL] [Abstract][Full Text] [Related]
26. Surgical management of adrenocortical carcinoma.
Ranvier GG; Inabnet WB
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
[TBL] [Abstract][Full Text] [Related]
27. Primary hyperparathyroidism associatiated with aldosterone-producing adrenocortical adenoma and breast cancer: relation to MEN1 gene.
Honda M; Tsukada T; Horiuchi T; Tanaka R; Yamaguchi K; Obara T; Miyakawa H; Yamaji T; Ishibashi M
Intern Med; 2004 Apr; 43(4):310-4. PubMed ID: 15168774
[TBL] [Abstract][Full Text] [Related]
28. Cortisol as a possible marker of metastatic adrenocortical carcinoma: a case report with 3-year follow-up.
Schwarte S; Brabant EG; Bastian L; Bruns F
Anticancer Res; 2007; 27(4A):1917-20. PubMed ID: 17649795
[TBL] [Abstract][Full Text] [Related]
29. Expectorated metastatic adrenocortical carcinoma: a rare presentation of a rare tumour.
Douglas A; Attanoos R
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32601137
[TBL] [Abstract][Full Text] [Related]
30. Pseudoglandular myxoid adenoma of the adrenal gland.
Dundr P; Novák K
Pathol Res Pract; 2003; 199(7):493-6. PubMed ID: 14521267
[TBL] [Abstract][Full Text] [Related]
31. A rare association of two endocrine tumours: non-functional oncocytic adrenocortical carcinoma and Papillary thyroid carcinoma.
Ruiz-Sánchez JG; Parra Ramírez P; Lisbona Catalán A
Horm Mol Biol Clin Investig; 2021 Mar; 42(2):199-201. PubMed ID: 33675218
[TBL] [Abstract][Full Text] [Related]
32. Integrative computational immunogenomic profiling of cortisol-secreting adrenocortical carcinoma.
Baechle JJ; Hanna DN; Sekhar KR; Rathmell JC; Rathmell WK; Baregamian N
J Cell Mol Med; 2021 Nov; 25(21):10061-10072. PubMed ID: 34664400
[TBL] [Abstract][Full Text] [Related]
33. Myxoid adrenal cortical carcinoma presenting as primary hyperaldosteronism: case report and review of the literature.
Hsieh MS; Chen JH; Lin LW
Int J Surg Pathol; 2011 Dec; 19(6):803-7. PubMed ID: 20444728
[TBL] [Abstract][Full Text] [Related]
34. [Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].
Drbalová K; Herdová K; Krejčí P; Nývltová M; Solař S; Vedralová L; Záruba P; Netuka D; Bavor P
Vnitr Lek; 2016; 62(9 Suppl 3):140-149. PubMed ID: 27734708
[TBL] [Abstract][Full Text] [Related]
35. Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
Abdel-Aziz TE; Rajeev P; Sadler G; Weaver A; Mihai R
World J Surg; 2015 May; 39(5):1268-73. PubMed ID: 25526921
[TBL] [Abstract][Full Text] [Related]
36. Cardiac and caval invasion of left adrenocortical carcinoma.
Yavascaoglu I; Yilmaz M; Kordan Y
Urol Int; 2008; 81(2):244-6. PubMed ID: 18758230
[TBL] [Abstract][Full Text] [Related]
37. A case of adrenocortical carcinoma accompanying secondary acute adrenal hypofunction postoperation.
Kou K; Zhang H; Zhang C; Xie E; Chen Y; Wang G; Lv G
World J Surg Oncol; 2018 Mar; 16(1):43. PubMed ID: 29506536
[TBL] [Abstract][Full Text] [Related]
38. Aldosterone-secreting adrenal cortical carcinoma. A case report and review of the literature.
Griffin AC; Kelz R; LiVolsi VA
Endocr Pathol; 2014 Sep; 25(3):344-9. PubMed ID: 24682757
[TBL] [Abstract][Full Text] [Related]
39. Aldosterone-producing adrenocortical carcinoma with prominent hepatic metastasis diagnosed by liver biopsy: a case report.
Ohashi K; Hayashi T; Sakamoto M; Iuchi H; Suzuki H; Ebisawa T; Tojo K; Sasano H; Utsunomiya K
BMC Endocr Disord; 2016 Jan; 16():3. PubMed ID: 26772981
[TBL] [Abstract][Full Text] [Related]
40. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
